Assessment of geriatric information on the drug label for commonly prescribed drugs in older people

Journal of the American Geriatrics Society

Volumn 53, Issue 5, 2005, Pages 891-894

  Steinmetz, Karen L ^a   Coley, Kim C ^a   Pollock, Bruce G ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Aged; Drug labeling; Drug prescriptions; Drug therapy

Indexed keywords

ALPRAZOLAM; AMLODIPINE; ATENOLOL; ATORVASTATIN; CLOPIDOGREL; DEXTROPROPOXYPHENE; DIGOXIN; DILTIAZEM; FUROSEMIDE; GABAPENTIN; GLYCERYL TRINITRATE; HYDROCODONE BITARTRATE PLUS PARACETAMOL; ISOSORBIDE; LEVOFLOXACIN; LEVOTHYROXINE; LISINOPRIL; LORAZEPAM; METOPROLOL; NIZATIDINE; OXYCODONE; PANTOPRAZOLE; PARACETAMOL; PERCOCET; POTASSIUM; PREDNISONE; QUINAPRIL; SIMVASTATIN; TAMSULOSIN; UNINDEXED DRUG; WARFARIN;

ARTICLE; AUTOMATION; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INFORMATION; DRUG LABELING; DRUG MARKETING; DRUG SAFETY; PATIENT EDUCATION; PHARMACOKINETICS; PRESCRIPTION; AGED; GERIATRICS; HEALTH CARE QUALITY; HUMAN; METHODOLOGY; STANDARD; UNITED STATES;

AGED; DRUG LABELING; GERIATRICS; HUMANS; QUALITY ASSURANCE, HEALTH CARE; UNITED STATES;

EID: 20444484157     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2005.53273.x     Document Type: Article

References (16)

1. McCloskey A. Cost Overdose. Growth in Drug Spending for the Elderly 1992-2010 (Publication no. 00-107). Washington, DC: Families USA, 2000.
2. Atkin PA, Veitch PC, Veitch EM et al. The epidemiology of serious adverse drug reactions among the elderly. Drugs Aging 1999;14:141-152.
3. Gurwitz JH, Col NF, Avorn J. The exclusion of elderly and women from clinical trials in myocardial infarction. JAMA 1992;268:1417-1422.
4. Turnheim K. When drug therapy gets old: Pharmacokinetics and pharmacodynamics in the elderly. Exp Gerentol 2003;38:842-853.
5. Bressler R, Bahl JJ. Principles of drug therapy for the elderly patient. Mayo Clin Proc 2003;78:1564-1577.
6. Fabian TJ, Amico JA, Kroboth PD et al. Paroxetine-induced hyponatremia in the elderly due to syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J Geriatr Psychiatry Neurol 2003;16:160-164.
7. Masand PS, Side effects of antipsychotics in the elderly. J Clin Psychiatry 2000;61(Suppl 8):43-49.
8. Specific requirements on content and format of labeling for human prescription drugs; Addition of 'Geriatric Use' subsection in the labeling. U.S. Department of Health and Human Services. 62 FR 45313 August 17, 1997.
9. Guidance for Industry Content and Format for Geriatric Labeling. U.S. Department of Health and Human Services, 66 FR 51053-51054, 2001.
10. Physicians' Desk Reference, 57th Ed. Montvale, NJ: Medical Economics, 2003.
11. Physicians' Desk Reference, 55th Ed. Montvale, NJ: Medical Economics, 2001.
12. Nissen D, ed. Mosby's Drug Consult. St. Louis, MO: Mosby, Inc., 2003.
13. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomized placebo-controlled trial. Lancet 2002;360:7-22.
14. LaRosa JC, Applegate W, Grouse JR 3rd et al. Cholesterol lowering in the elderly: Results of the Cholesterol Reduction in Seniors Program (CRISP) pilot study. Arch Intern Med 1994;154:529-539.
15. Shepherd J, Blauw GJ, Murphy MB et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomized controlled trial. Lancet 2002;360:1623-1630.
16. Hjalmarson A, Goldstein S, Fagerberg B et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF), JAMA 2000;283:1295-1302.